NASDAQ:ASRT

ASRT DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP – Important March 5, 2024 Deadline Reminder in Assertio Holdings, Inc. (ASRT) Securities Class Action Lawsuit

Retrieved on: 
Friday, February 9, 2024
Fraud, IRS, EPS, Suppository, News, Acquisition, FDA, District court, Q3, Medicare, Adjustment, Lead, LLP, Person, COPY, Court, CFTC

The action charges Assertio with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.

Key Points: 
  • The action charges Assertio with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • As a result of Assertio’ s materially misleading statements and omissions to the public, Assertio’ s investors have suffered significant losses.
  • Kessler Topaz Meltzer & Check, LLP encourages Assertio investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The class action complaint against Assertio, Shapiro v. Assertio Holdings, Inc., et al., Case No.

DEADLINE ALERT for MSS, ASRT, DADA, BNTX: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Thursday, February 8, 2024
The Company, Investment, COVID-19, Pfizer–BioNTech COVID-19 vaccine, Suite, Sale, Class, BioNTech, Supermarket, Risk, Marketing, Spectrum, EB-5, Telephone, Pfizer, Law

BENSALEM, Pa., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • BENSALEM, Pa., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected] .
  • Law Offices of Howard G. Smith

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Assertio Holdings, Inc.(ASRT) Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Thursday, February 8, 2024
CLASS, Acquisition, Spectrum Pharmaceuticals, Sale, ASRT, Risk, LLP, Telephone, NEXT, Court, COST

NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Assertio Holdings, Inc. ("Assertio Holdings" or the "Company") (NASDAQ: ASRT) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Assertio Holdings, Inc. ("Assertio Holdings" or the "Company") (NASDAQ: ASRT) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Assertio Holdings investors who were adversely affected by alleged securities fraud between March 29, 2023 and November 8, 2023.
  • Follow the link below to get more information and be contacted by a member of our team:
    ASRT investors may also contact Joseph E. Levi, Esq.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

ASSERTIO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options

Retrieved on: 
Thursday, February 8, 2024
EPS, Suppository, News, Acquisition, FDA, Spectrum Pharmaceuticals, Food, Advertising, Woman, Sale, Adjustment, Risk, Spectrum, LLP, Learning, Court, Cryptocurrency

NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) and reminds investors of the March 5, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Key Points: 
  • If you suffered losses exceeding $25,000 investing in Assertio stock or options between March 9, 2023 and November 8, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext.
  • Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
  • In July 2023, Assertio acquired Spectrum Pharmaceuticals, Inc. ("Spectrum"), a biopharmaceutical company focused on novel and targeted oncology, along with Spectrum's injection asset Rolvedon (the "Spectrum Acquisition").
  • Faruqi & Faruqi, LLP also encourages anyone with information regarding Assertio’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

DEADLINE ALERT for VNET, MSS, and ASRT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Wednesday, February 7, 2024
Spectrum, Register, Supermarket, Investment, Law, Risk, Sale, Defendant, Suite, EB-5, Facility, Complaint, Security (finance)

LOS ANGELES, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • The Law Offices of Frank R. Cruz, Los Angeles

ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Assertio Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ASRT

Retrieved on: 
Tuesday, February 6, 2024
Titan, Class, ASRT, Spectrum, Advertising, Spectrum Pharmaceuticals, Risk, Acquisition, Sale, Court, Tobacco

WHAT TO DO NEXT: To join the Assertio class action, go to https://rosenlegal.com/submit-form/?case_id=21676 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Assertio class action, go to https://rosenlegal.com/submit-form/?case_id=21676 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

ASSERTIO HOLDINGS, INC. (NASDAQ: ASRT) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Assertio Holdings, Inc.

Retrieved on: 
Tuesday, February 6, 2024
ASRT, Spectrum, Action Replay, Spectrum Pharmaceuticals, News, Patient, Rheumatoid arthritis, District court, Risk, Acquisition, Advertising, Sale, Defendant, Complaint, Court, Security (finance)

If you purchased or acquired Assertio securities, and/or would like to discuss your legal rights and options please visit Assertio Holdings, Inc.

Key Points: 
  • If you purchased or acquired Assertio securities, and/or would like to discuss your legal rights and options please visit Assertio Holdings, Inc.
  • If you wish to serve as lead plaintiff, you must move the Court no later than March 5, 2024.
  • If you purchased or acquired Assertio securities, and/or would like to discuss your legal rights and options please visit Assertio Holdings, Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against VNET, Assertio, and Cummins and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, February 6, 2024
EPS, ASRT, Spectrum, Spectrum Pharmaceuticals, News, Patient, Suppository, Cayman, P.C, Complaint, FDA, Adjustment, Rheumatoid arthritis, Food, CMI, Executive, Risk, Acquisition, Learning, Sale, Defendant, Facility, Cryptocurrency

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.

Key Points: 
  • Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
  • On this news, the Company’s share price fell $0.20, or 3.2% on February 13, 2023, on unusually heavy trading volume.
  • According to the complaint, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.
  • For more information on the Cummins class action go to: https://bespc.com/cases/CMI

Assertio Holdings, Inc. Investors: Company Investigated by the Portnoy Law Firm

Retrieved on: 
Monday, February 5, 2024
ASRT, News, Suppository, FDA, Food, Zydus Lifesciences, Acquisition

​LOS ANGELES, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Assertio stock. Assertio investors are encouraged to contact the firm to discuss their legal rights.

Key Points: 
  • ​LOS ANGELES, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT ) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Assertio stock.
  • Assertio investors are encouraged to contact the firm to discuss their legal rights.
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing.

Analyst Slashes Assertio Holdings (ASRT) Price Target Amid CEO’s Departure and Securities Fraud Suit – Hagens Berman

Retrieved on: 
Monday, February 5, 2024
EPS, Hagens Berman, SAN, ASRT, Pressure, Spectrum, Person, Suppository, News, FDA, Risk, Sale, Cryptocurrency

SAN FRANCISCO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Assertio Holdings, Inc. (NASDAQ: ASRT) investors who suffered substantial losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Assertio Holdings, Inc. (NASDAQ: ASRT) investors who suffered substantial losses to submit your losses now .
  • Assertio Holdings, Inc. (ASRT) Securities Fraud Class Action:
    On Jan. 4, 2024, securities analyst Sidoti & Company lowered its price target of Assertio Holdings (ASRT) shares by 25% and also significantly cut its 2024 and 2025 revenue estimates.
  • First, on Jan. 5, ASRT shares nose-dived after the Company announced that CEO Dan Peisert was stepping down.
  • Notably, Assertio characterized Peisert’s separation from the company as an “involuntary termination.”
    Second, immediately following Peisert’s termination, ASRT investors filed a securities fraud class action suit alleging Assertio securities were artificially inflated for the period of Mar.